Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE171074 |
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer
|
88 |
|
Joanna Achinger-Kawecka | Dec 12, 2021 | |||
GSE216989 |
Decitabine treatment reveals a functional role of DNA hypomethylation in organising enhancer-promoter interactions
|
24 |
|
Joanna Achinger-Kawecka | Aug 07, 2023 | |||
GSE236247 |
The Interferon γ Pathway Enhances Pluripotency and X-Chromosome Reactivation in iPSC Reprogramming
|
68 |
|
Mercedes Barrero | Aug 07, 2024 | |||
GSE184757 |
Study of 5mC-DNA, m6A-RNA and RNA-expression in HeLa, ES and EB
|
306 | Martin Bizet | Jan 10, 2025 | ||||
GSE168722 |
DNMT3A haploinsufficiency causes dichotomous DNA methylation defects at enhancers in mature human immune cells
|
76 |
|
Minji Byun | Apr 12, 2021 | |||
GSE248183 |
Modeling the next-generation of rhabdomyosarcoma organoids to predict effective drug combinations
|
71 | Thomas Diot | Dec 19, 2023 | ||||
GSE101864 |
Chronic Cigarette Smoke-Induced Epigenomic, gene expression and chromatin changes in Bronchial Epithelial Cells
|
86 | Hariharan Easwaran | Oct 21, 2017 | ||||
GSE210435 |
TET2 Mutant Clonal Hematopoiesis Enhances Severity of COVID-19 Related Cytokine Release Syndrome and is Associated with Increased Mortality.
|
363 | Alexandre Gaspar-Maia | Aug 13, 2024 | ||||
GSE248811 |
Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and correlate with tumor morphology.
|
128 |
|
Swenja Gödicke | Jan 31, 2024 | |||
GSE242994 |
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutations
|
294 | Karoline Hack | Jan 26, 2024 | ||||
GSE182317 |
Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia
|
171 |
|
Rico Hagelaar | Apr 29, 2023 | |||
GSE19247 |
Preclinical Validation of a Microarray Method for Full Molecular Karyotyping of Blastomeres in a 24-hour Protocol
|
|
622 |
|
David Scott Johnson | Dec 04, 2009 | ||
GSE22864 |
Comprehensive Analysis of Karyotypic Mosaicism between Trophectoderm and Inner Cell Mass
|
|
130 |
|
David Scott Johnson | Sep 28, 2010 | ||
GSE198450 |
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma
|
163 | Alex G Lee | May 15, 2023 | ||||
GSE252723 |
Endocrine disruptor-induced epimutagenesis in vitro: Insight into molecular mechanisms
|
84 |
|
Jake Dean Lehle | Jan 31, 2024 | |||
GSE116057 |
Refined detection and phasing of structural aberrations in pediatric acute lymphoblastic leukemia by linked-read whole genome sequencing
|
21 | Yanara Marincevic-Zuniga | Mar 02, 2020 | ||||
GSE94962 |
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown
|
20 |
|
Aram S Modrek | Nov 09, 2017 | |||
GSE227488 |
Human CCR6+ Th cells show both an extended stable gradient of Th17 activity and imprinted plasticity
|
159 | Timothy G Myers | Mar 17, 2023 | ||||
GSE229769 |
Preclinical quality, safety and efficacy of a human embryonic stem cell-derived product for treatment of people with moderate Parkinson’s Disease (STEM-PD)
|
9 |
|
Malin Parmar | Sep 25, 2023 | |||
GSE128795 |
Dicer sequencing, whole genome methylation profiling and RNA sequencing analysis in basal cell carcinoma
|
31 | Michael Sand | Oct 25, 2019 |